Mixed Results for Gilead Sciences' COVID-19 Treatment

Cory Renauer, The Motley Fool
Mixed Results for Gilead Sciences' COVID-19 Treatment

Remdesivir helped patients recover faster, but the experimental coronavirus treatment didn't lower patients' risk of death.